2014
DOI: 10.2215/cjn.02440213
|View full text |Cite
|
Sign up to set email alerts
|

Association between AKI and Long-Term Renal and Cardiovascular Outcomes in United States Veterans

Abstract: Background and objectives AKI is associated with major adverse kidney events (MAKE): death, new dialysis, and worsened renal function. CKD (arising from worsened renal function) is associated with a higher risk of major adverse cardiac events (MACE): myocardial infarction (MI), stroke, and heart failure. Therefore, the study hypothesis was that veterans who develop AKI during hospitalization for an MI would be at higher risk of subsequent MACE and MAKE.Design, setting, participants, & measurements Patients in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
228
0
4

Year Published

2015
2015
2020
2020

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 271 publications
(241 citation statements)
references
References 42 publications
4
228
0
4
Order By: Relevance
“…The risk of subsequent coronary events or stroke was increased in patients with AKI in most studies (8,14,15). A greater risk of hospitalization for heart failure after myocardial infarction or percutaneous coronary revascularization procedure was also noted (7,8).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The risk of subsequent coronary events or stroke was increased in patients with AKI in most studies (8,14,15). A greater risk of hospitalization for heart failure after myocardial infarction or percutaneous coronary revascularization procedure was also noted (7,8).…”
Section: Discussionmentioning
confidence: 99%
“…More recently, the development of acute kidney injury (AKI) was shown to predict subsequent renal failure and cardiovascular events in selected populations (6)(7)(8).…”
mentioning
confidence: 99%
“…The AKIN criteria were the most contemporary criteria available at the time of the initial study design; the Kidney Disease: Improving Global Outcomes (KDIGO) criteria (Table 1) were published during the course of protocol development. Major secondary efficacy endpoints included the percentage of patients who developed ≥1 of the following composite endpoints: death, need for any renal replacement therapy (RRT) during the 90‐day postoperative period, or ≥25% reduction in eGFR from baseline to 90 days postsurgery (major adverse kidney events [MAKE])21; percentage of patients who developed AKI as defined by the RIFLE19 or KDIGO22 criteria; maximal changes from baseline in novel AKI biomarkers over a 72‐hour period after clamp release; and length of intensive care unit (ICU) and hospital stays. Per the study protocol, the aforementioned endpoints were only followed out to 90 days postsurgery.…”
Section: Methodsmentioning
confidence: 99%
“…As the evidence linking AKI with loss of kidney function [45][46][47][77][78][79][80] , hypertension 81,82 , cardiovascular disease 49,50,83 , and death 46,[83][84][85][86][87] accumulates, determining the optimal care for this growing population is critical. The American Society of Nephrology AKI Advisory Group has highlighted the transition of care as a potential opportunity to reduce the long-term impact of AKI 88 , and hence, AKD.…”
Section: Follow-up Carementioning
confidence: 99%